FibroBiologics Capital Raise of $500K
FibroBiologics closed a $0.5 million private placement with its Chief Scientific Officer, Hamid Khoja, Ph.D., for the purchase of 298,508 shares and accompanying warrants. The securities were sold at a combined purchase price of $1.675 per unit, with proceeds intended for general corporate purposes and working capital. Additionally, shareholders approved the issuance of over 8 million shares related to a prior June 2026 securities purchase agreement.
- Value
- $500K
- Counterparty
- Hamid Khoja, Ph.D.